Immunogenicity
No participant receiving GSK3772847 in cohort 1, 2, or 3 tested positive for anti‐GSK3772847 binding antibodies in the confirmatory assay. One participant from cohort 4 (Chinese) confirmed positive results for anti‐GSK3772847 binding antibodies (titer 80) on Day 57 and Day 85.